{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:59:41Z","timestamp":1761919181384},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,12,18]],"date-time":"2008-12-18T00:00:00Z","timestamp":1229558400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1007\/s12185-008-0224-y","type":"journal-article","created":{"date-parts":[[2008,12,17]],"date-time":"2008-12-17T08:58:08Z","timestamp":1229504288000},"page":"123-125","source":"Crossref","is-referenced-by-count":4,"title":["Emergence of abnormal clone with monsomy 7 in Philadelphia negative cells of CML patients treated with tyrosine kinase inhibitors"],"prefix":"10.1007","volume":"89","author":[{"given":"Monika Ribeiro","family":"de Mello Conchon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Israel","family":"Bendit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Kumeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalton","family":"de Alencar Fischer Chamone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro Enrique","family":"Dorlhiac-Llacer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,12,18]]},"reference":[{"issue":"7","key":"224_CR1","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/sj.leu.2402634","volume":"16","author":"MK Andersen","year":"2002","unstructured":"Andersen MK, Pedersen-Bjergaard J, Kjeldsen L, et al. Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8. Leukemia. 2002;16(7):1390\u20133. doi:\n                    10.1038\/sj.leu.2402634\n                    \n                  .","journal-title":"Leukemia"},{"issue":"3","key":"224_CR2","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/sj.leu.2402848","volume":"17","author":"ME O\u2019Dwyer","year":"2003","unstructured":"O\u2019Dwyer ME, Gatter KM, Loriaux M, et al. Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate. Leukemia. 2003;17(3):481\u20137. doi:\n                    10.1038\/sj.leu.2402848\n                    \n                  .","journal-title":"Leukemia"},{"issue":"2","key":"224_CR3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/sj.leu.2402791","volume":"17","author":"P Meeus","year":"2003","unstructured":"Meeus P, Demuynck H, Martiat P, et al. Sustained, clonal karyotype abnormalities in the Philadelphia chromosome negative cells of CML patients successfully treated with imatinib. Leukemia. 2003;17(2):465\u20137.","journal-title":"Leukemia"},{"issue":"8","key":"224_CR4","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/sj.leu.2403399","volume":"18","author":"C Terre","year":"2004","unstructured":"Terre C, Eclache V, Rousselot P, et al. Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia. Leukemia. 2004;18(8):1340\u20136. doi:\n                    10.1038\/sj.leu.2403399\n                    \n                  .","journal-title":"Leukemia"},{"issue":"9","key":"224_CR5","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/cncr.11729","volume":"98","author":"J Medina","year":"2003","unstructured":"Medina J, Kantarjian H, Talpaz M, et al. Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase. Cancer. 2003;98(9):1905\u201311. doi:\n                    10.1002\/cncr.11729\n                    \n                  .","journal-title":"Cancer"},{"issue":"5","key":"224_CR6","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1182\/blood-2002-07-2053","volume":"101","author":"T Bumm","year":"2003","unstructured":"Bumm T, Muller C, Al-Ali HK, et al. Emergence of clonal cytogenetic abnormalities in Ph\u2014 cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority. Blood. 2003;101(5):1941\u20139. doi:\n                    10.1182\/blood-2002-07-2053\n                    \n                  .","journal-title":"Blood"},{"issue":"8","key":"224_CR7","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1182\/blood-2006-04-017400","volume":"108","author":"C Kovitz","year":"2006","unstructured":"Kovitz C, Kantarjian H, Garcia-Manero G, et al. Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia. Blood. 2006;108(8):2811\u20133. doi:\n                    10.1182\/blood-2006-04-017400\n                    \n                  .","journal-title":"Blood"},{"issue":"4","key":"224_CR8","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/sj.leu.2404139","volume":"20","author":"DM Ross","year":"2006","unstructured":"Ross DM, Branford S, Moore S, Hughes TP. Limited clinical value of regular bone marrow cytogenetic analysis in imatinib-treated chronic phase CML patients monitored by RQ-PCR for BCR-ABL. Leukemia. 2006;20(4):664\u201370. doi:\n                    10.1038\/sj.leu.2404139\n                    \n                  .","journal-title":"Leukemia"},{"issue":"3","key":"224_CR9","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/sj.leu.2402842","volume":"17","author":"YL Chee","year":"2003","unstructured":"Chee YL, Vickers MA, Stevenson D, et al. Fatal myelodysplastic syndrome developing during therapy with imatinib mesylate and characterised by the emergence of complex Philadelphia negative clones. Leukemia. 2003;17(3):634\u20135. doi:\n                    10.1038\/sj.leu.2402842\n                    \n                  .","journal-title":"Leukemia"},{"issue":"9","key":"224_CR10","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/ajh.20859","volume":"82","author":"JT Navarro","year":"2007","unstructured":"Navarro JT, Feliu E, Grau J, et al. Monosomy 7 with severe myelodysplasia developing during imatinib treatment of Philadelphia-positive chronic myeloid leukemia: two cases with a different outcome. Am J Hematol. 2007;82(9):849\u201351. doi:\n                    10.1002\/ajh.20859\n                    \n                  .","journal-title":"Am J Hematol"},{"issue":"2","key":"224_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cancergencyto.2006.12.011","volume":"176","author":"A Zeidan","year":"2007","unstructured":"Zeidan A, Kakati S, Anderson B, et al. Monosomy 7 in t(9;22)-negative cells during nilotinib therapy in an imatinib-resistant chronic myeloid leukemia case. Cancer Genet Cytogenet. 2007;176(2):169\u201371. doi:\n                    10.1016\/j.cancergencyto.2006.12.011\n                    \n                  .","journal-title":"Cancer Genet Cytogenet"},{"issue":"3","key":"224_CR12","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1365-2141.2007.06678.x","volume":"138","author":"A Fabarius","year":"2007","unstructured":"Fabarius A, Giehl M, Frank O, et al. Centrosome aberrations after nilotinib and imatinib treatment in vitro are associated with mitotic spindle defects and genetic instability. Br J Haematol. 2007;138(3):369\u201373. doi:\n                    10.1111\/j.1365-2141.2007.06678.x\n                    \n                  .","journal-title":"Br J Haematol"},{"issue":"8","key":"224_CR13","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1182\/blood-2007-05-092437","volume":"110","author":"VA Melo De","year":"2007","unstructured":"De Melo VA, Milojkovic D, Khorashad JS, et al. Philadelphia-negative clonal hematopoiesis is a significant feature of dasatinib therapy for chronic myeloid leukemia. Blood. 2007;110(8):3086\u20137. doi:\n                    10.1182\/blood-2007-05-092437\n                    \n                  .","journal-title":"Blood"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-008-0224-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-008-0224-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-008-0224-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-008-0224-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T05:01:23Z","timestamp":1559451683000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-008-0224-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,18]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["224"],"URL":"https:\/\/doi.org\/10.1007\/s12185-008-0224-y","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,18]]}}}